The present invention relates to an opioid antagonist composition comprising an opioid antagonist dispersed in a matrix that renders the antagonist substantially non-releasable, wherein the matrix comprises one or more of a phaimaceutically acceptable hydrophobic material and the antagonist is unavailable to be absorbed during its transit through the gastrointestinal system.